Prostate cancer has an enemy more. Dutasteride is the drug that, according to research results Reduce (Reduction by Dutasteride of Prostate Cancer Events) published in the journal New England Journal of Medicine, would be able to significantly reduce the chances of developing prostate cancer in subjects at risk.
Of the centers that participated in the study is also the San Raffaele Hospital in Milan through the collaboration of Professor. Francesco Montorsi, Professor of Urology, which has been one of the coordinators.
The Dutasteride is already prescribed by urologists for the treatment of urinary disorders associated with benign prostatic hypertrophy phenomenon. Its action blocks the transformation of cells within the prostate of testosterone-hydro-testosterone evolved biologically active hormone that affects the DNA. Thus, the Dutasteride works by reducing the size of the prostate gland. According to scholars, however, the drug could also prevent prostate cancer in susceptible individuals.
Physicians who participated in the study Reduce examined during four years around 6,300 men between 50 and 75 years with a PSA value between 2.5 and starting 10 ng / ml. Patients were divided into two groups: the first was given a tablet of 0.5 mg per day of Dutasteride, a second simple placebo. The volunteers underwent prostate biopsy after 2 years of treatment and at the end of the study, and whenever you suspect the presence of a tumor. The results showed that patients treated with Dutasteride, the risk of developing prostate cancer was reduced by 22.8 percent compared to placebo. The positive effect, however, covered only the less aggressive tumors, while more difficult cases the difference between patients treated with the drug and the other was statistically insignificant.
Prof. Montorsi said of the results: "This study offers a new option to patients who carried one or more prostate biopsies but found negative for cancer. These patients typically have elevated PSA values or a visit suspected prostate. In these cases, treatment with Dutasteride is a therapeutic option that should be discussed with the patient. "
The drug represents a new hope for the prevention of prostate cancer that is known, is the most common form of cancer among men and the second for mortality after lung cancer.
http://italiasalute.leonardo.it/tumoreprostata.asp
|
This is great writing about the Prostate cancer. Prostate cancer is classified in stages. Prostate cancer is the main cancer affecting men in North America.
Stage 4 breast cancer